Insulin has been the subject of many news stories recently as the high cost of insulin and other drugs has led to two US federal initiatives aimed at allowing the bulk importation of lower cost Canadian drugs. A reliable and consistent supply of insulin enables Canadians with type 1 diabetes to live their lives fully, but this recent news shouldn’t be cause for undue alarm. While these initiatives were recently announced they won’t become law for 3-4 months, and there is no guarantee that they will have the intended affect at that time. Dave Prowten, CEO and President of JDRF Canada, issued a statement in response to the recent news and rest assured, and JDRF is committed to ensuring everyone living with T1D in Canada can keep their right to reliable insulin access.
